Stocks · News reference
Establishment Labs Says FDA Approved 28 New Sizes Of Motiva Breast Implants, Available Before Year-End
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
Establishment Labs Extends Master Supply Agreement With NuSil Technology To December 31, 2031
On October 14, 2026, Establishment Labs Holdings Inc. (the "Company"), through its wholly owned subsidiary, Establishment Labs, S.A. ("ELSA"), entered into Amendment No. 3 ("Amendment No. 3") to
8-K filing — ESTABLISHMENT LABS HOLDINGS INC. (ESTA)
Filed: 2026-10-15 AccNo: 0001104659-26-115928 Size: 225 KB Item 1.01: Entry into a Material Definitive Agreement Item 9.01: Financial Statements and Exhibits
Establishment Labs Hldgs Reports Q2 2026 Results: Full Earnings Call Transcript
Establishment Labs Hldgs (NASDAQ:ESTA) reported second-quarter financial results on Thursday. The transcript from the company's second-quarter earnings call has been provided below. Benzinga APIs provide real-time